Thrombophilia Tests in the package: 5 Sample: blood Result: 7 working days

Extended profile of genetic risk factors for thrombophilia: mutations - factor V Leiden (G1691A), factor V R2 haplotype (H1299R), factor II (prothrombin G20210A), MTHFR (C677T, A1298C), factor XIII (V34L)

This profile is for people who have had a thrombosis, women with repeated pregnancy losses or pregnancy complications, and people with a family history of thrombosis. From a blood sample it examines inherited variants in the genes for factor V (Leiden and R2), factor II, MTHFR, factor XIII and PAI-1, which affect blood clotting and clot breakdown.

Package code C2068 Preparing for laboratory tests

Some laboratory tests require specific preparation by the patient, concerning diet before sampling and the time of day at which to come to the laboratory for sampling. The patient can be informed about this by their doctor or by the staff of Sante Laboratorije. Many other tests, however, need no prior preparation, and samples do not have to be collected at a particular time or in relation to meals.

For information, contact us on +381 11 27 62 199 | +381 64 65 87 607 or in writing at office@clinica-sante.rs.

Extended profile of genetic risk factors for thrombophilia: mutations - factor V Leiden (G1691A), factor V R2 haplotype (H1299R), factor II (prothrombin G20210A), MTHFR (C677T, A1298C), factor XIII (V34L)

Preparation and sampling

Preparation
Guide to preparing for tests
Sample
Blood
Results available in
7 working days
Where it is done
All laboratories and map

Description

Who the package is for

The extended genetic thrombophilia risk profile is a molecular genetic test that detects inherited variants in genes involved in blood clotting and in breaking down clots (fibrinolysis). These variants can increase the tendency to form blood clots, most often in the veins (deep vein thrombosis, pulmonary embolism) and less often in the arteries, and can contribute to pregnancy complications such as pregnancy loss, pre-eclampsia and fetal growth restriction, especially in combination with other risk factors.

The profile is recommended for:

  • people who have had a deep vein thrombosis or pulmonary embolism at a young age or without a known cause;
  • people with repeated thromboses or a thrombosis in an unusual site (blood vessels of the brain, bowel or liver);
  • women with repeated pregnancy losses or other complications in previous pregnancies;
  • people whose relatives have had a thrombosis or carry confirmed mutations;
  • before hormone treatment, chemotherapy or major surgery, when the doctor considers it necessary.

What the package includes

  • Factor V Leiden (G1691A) – the most common inherited cause of thrombophilia; it causes resistance to activated protein C and increases the risk of venous thrombosis about 5–10-fold in heterozygotes and up to 80-fold in homozygotes.
  • Factor V R2 haplotype (H1299R) – a factor V gene variant with a small effect on its own, which increases the risk when combined with factor V Leiden.
  • Factor II (prothrombin G20210A) – leads to higher prothrombin levels and a stronger tendency to clot; it increases the risk of venous thromboembolism and can contribute to pregnancy complications (pre-eclampsia, repeated pregnancy losses).
  • MTHFR (C677T, A1298C) – variants of an enzyme important for folic acid and homocysteine metabolism; C677T reduces the enzyme's activity and can lead to raised homocysteine, especially with folate deficiency, in pregnancy or with contraceptives, while A1298C has a milder effect that can be stronger in combination with C677T.
  • Factor XIII (V34L) – a variant that affects the structure and stabilisation of the fibrin network of the clot; depending on the other variants present (factor V, factor II, PAI-1), its effect is protective in some cases and variable in others.
  • PAI-1 (4G/5G) – the 4G allele is linked to higher levels of plasminogen activator inhibitor-1, weaker clot breakdown and a greater tendency to thrombosis, as well as to pregnancy losses and pre-eclampsia.

Why these tests together

A tendency to thrombosis rarely depends on a single variant: the risk arises from a combination of several inherited factors and acquired circumstances (pregnancy, hormone treatment, surgery, immobility, obesity, cancer). That is why one test examines variants affecting blood clotting (factor V, factor II, factor XIII), clot breakdown (PAI-1) and homocysteine metabolism (MTHFR).

The genetic result does not change during life and is not affected by anticoagulant treatment or the current state of blood clotting, so the test only needs to be done once.

Preparation

  • You do not need to fast, and the sample can be taken at any time of day.
  • Anticoagulant treatment does not affect the result and should not be stopped.
  • If you have had a bone marrow or blood stem cell transplant, tell the laboratory, as the DNA in your blood then comes from the donor.

Sample

Venous blood (EDTA tube), from which DNA is extracted.

Interpreting the results

For each variant tested, the genotype is reported: normal (no variant), heterozygous (variant on one copy of the gene) or homozygous (variant on both copies).

  • Factor V Leiden and prothrombin G20210A are recognised risk factors for venous thrombosis; the risk is higher in homozygotes and in people with several variants at the same time.
  • MTHFR, PAI-1 and factor XIII variants are susceptibility markers, not direct causes of thrombophilia; having them does not mean that a thrombosis will definitely occur. International guidelines do not recommend MTHFR testing to assess the risk of venous thrombosis or to decide on anticoagulant treatment.
  • The profile does not cover other causes of thrombophilia, such as protein C, protein S or antithrombin deficiency and antiphospholipid syndrome, and does not measure the levels of these proteins in the blood; there are separate tests for these.
  • The result has predictive, not diagnostic, value and is interpreted by a doctor (haematologist or geneticist) together with your personal and family medical history. If factor V or factor II variants are found, genetic counselling and testing of relatives can be helpful.

Your doctor interprets the result together with your symptoms and other findings.

Tests in the package

Single-test prices are online prices: 19.805 RSD separately, 19.800 RSD in the package.

How to order tests online?

Add the tests you want to your cart

Choose the tests you need and add them to your cart. Use the site search to find the tests you want more easily.

Pay online or at the laboratory

Payment method:

  • Online – payment uses 3D-Secure, a secure authentication protocol that minimises the risk of fraud.
  • At the laboratory – order your tests online and pay for them when you come to the laboratory.
Have your samples taken at one of our laboratories

After payment, you will receive an email confirming your order, with details of how to prepare for sampling. From then on, you can go to the Sante laboratory you chose when ordering your tests and have your samples taken.

Learn more
Back to top